Considering the Economics of Identifying and Fighting MRSA in a Hospital Setting
Recent estimates put the cost of MRSA infections in US hospitals between $3.2 billion and $4.2 billion each year1. Individual costs associated with treating an MRSA or S. aureus infection range from a few thousand dollars for minor cases up to well over $100,000 for complicated post-surgical infections.2 With these numbers, you would think its a no-brainer for hospitals to institute rigorous MRSA control procedures to keep the infection rate at a minimum. The problem is that there are costs associated with adopting MRSA surveillance and treatment procedures. Thus, and especially in a largely privatized healthcare environment such as the US, it unfortunately comes down to the issue of return on investment. Put simply: do the costs saved by preventing “x” number of infections justify the expenditures necessary to carry out the prevention program? Read More